ArticleClinical and molecular hepatology2023

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis.

Moon Haeng Hur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.